about
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to addr...
Read More
39.74
0.78
(2.00%)
162.1K
XNAS Volume
XNAS 17 Jul, 2026 11:23 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunovant Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..